WuXi PharmaTech (NYSE: WX) Expands Collaboration With A...(gh through put library compoundsynthesis...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
WuXi PharmaTech (NYSE: WX) Expands Collaboration With AstraZeneca
Date:6/10/2008
gh through put library compound synthesis and purification process with an annual capacity of one million compounds. Other lead generation services provided by the company include designing and synthesizing libraries, as well as templates for library synthesis, benchmark compound synthesis and custom synthesis.
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. For more information, please visit: http://www.wuxipharmatech.com .
'/>"/>
| SOURCE WuXi PharmaTech Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Quest PharmaTech Announces Positive Results from Phase I Clinical Trial of its Photodynamic Therapy for Actinic Keratosis
2. WuXi PharmaTech Announces First Quarter 2008 Results
3. WuXi PharmaTech (NYSE: WX) Appoints Dr. Peng Wang as VP of Discovery Biology
4. WuXi PharmaTech Schedules First Quarter 2008 Earnings Release on Tuesday, May 27, 2008
5. WuXi PharmaTech (NYSE: WX) Honored Among the BCG 50 Local Dynamos
6. Quest PharmaTech Receives Support from National Research Councils Industrial Research Assistance Program (NRC-IRAP) to develop Ultrasound Technology for the Treatment of Cancer
7. WuXi PharmaTech (Cayman) Inc. Announces Filing of Registration Statement For Follow-On and Secondary Offering
8. WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results
9. WuXi PharmaTech Schedules Fourth Quarter and Full Year 2007 Earnings Release on Wednesday, March 12, 2008
10. WuXi PharmaTech Completes Acquisition of AppTec
11. Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer
Post Your Comments:
Breaking Biology Technology:BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 2BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 3Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 2Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 3Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 4Microfluidics Chairman James N. Little, Ph.D., Announces Retirement from Board of Directors 2Microfluidics Chairman James N. Little, Ph.D., Announces Retirement from Board of Directors 3Reportlinker Adds Pharmacodynamic Assays 2Reportlinker Adds Pharmacodynamic Assays 3Reportlinker Adds Pharmacodynamic Assays 4
Other Biology Technology:Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock 2Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock 3Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock 4Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol 2Web-based Audio Interviews Keep Environment of Care Managers Up-to-Date on Key EC Compliance Issues 2
Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common StockGenencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic EthanolWeb-based Audio Interviews Keep Environment of Care Managers Up-to-Date on Key EC Compliance Issues
Breaking Biology News(10 mins):Tropical birds waited for land crossing between North and South America: UBC study 277 percent of European pigs are castrated without anesthetic 2University of the Basque Country research on plankton at Urdaibai 2Canadian scientists link fat hormone to death from potentially deadly blood infection 59994 1Canadian scientists link fat hormone to death from potentially deadly blood infection 59994 2ARVO Foundation and Pfizer Ophthalmics honor Carl B Camras with translational research award 59992 1Evolution of hyperactivity is focus of free public lecture at UC Riverside 10504 1Evolution of hyperactivity is focus of free public lecture at UC Riverside 10504 2
Other Biology News:Manomet Center awarded major NFWF grant to foster shorebird conservation 2Manomet Center awarded major NFWF grant to foster shorebird conservation 3Drug aimed at 2 bioterror agents blocks live viral infection, Weill Cornell team reports 2Drug aimed at 2 bioterror agents blocks live viral infection, Weill Cornell team reports 3New edition of a classic molecular biology textbook from CSHL Press and Benjamin Cummings 2
Biology Products:
Goat Anti-SIAH Interacting Protein Polyclonal Antibody, Unconjugated from AbcamMouse Anti-Transferrin, N-terminus Monoclonal Antibody, Unconjugated, Clone 236-18241 from Meridian Life Science, Inc.Anti-NSP-C (Neuroendocrine-Specific-Protein) Monoclonal Antibody, Unconjugated, Clone RNL-4 from CHEMICONRat Anti-Human CD267 Antibody, PE Conjugated from BD Biosciences Pharmingen
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |